Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2025-10-13
DOI
https://doi.org/10.1111/jdv.70080
Citations
3
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
6.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

Kim Papp, Matthew Zirwas, Jonathan I. Silverberg, Marjolein S. de Bruin-Weller et al.
3 citations
Journal of the European Academy of Dermatology and Venereology
Dermatology and Skin Diseases
6.01
article

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

Kim Papp, Matthew Zirwas, Jonathan I. Silverberg, Marjolein S. de Bruin-Weller, Matthias Augustin, Ryszard Galus, Gretel Trullenque, Soo Yeon Cheong, Sang Wook Son, Christophe Piketty, Vivian Laquer, Andrzej Kaszuba, Ágnes Drahos, Linda Stein Gold, Liliana Ulianov, Robert Sidbury, Walter K. Nahm, M. Tauber, Adam Reich, Laura Maintz, Anna Ryzhkova, Sady Alpizar, Diamant Thaçi, Ketty Peris, Kirk Barber
article en
3 citations

Abstract

No abstract available for this paper.
Journal of the European Academy of Dermatology and Venereology
Seattle Children's Hospital (US), University of Bonn (DE), Inserm (FR), Universität Hamburg (DE), University of Toronto (CA), George Washington University (US), Utrecht University (NL), Medical University of Warsaw (PL), University Hospital Bonn (DE), Agostino Gemelli University Polyclinic (IT), Orange Coast Memorial Medical Center (US), Henry Ford Hospital (US), Ansan University (KR), University of California San Diego (US), MSH Medical School Hamburg – University of Applied Sciences and Medical University (DE), Alberta Barley (CA), Merck Canada Inc. (Canada) (CA), Floridian Research Institute (US), Hospices Civils de Lyon (FR), Galderma (United States) (US), University Medical Center Hamburg-Eppendorf (DE), Synexus (Germany) (DE), Centrum Medyczne iMed24 (PL), Probity Medical Research (CA), Stedman Clinical Trials (US), West Coast Fertility Centers (US), University of the Sacred Heart (JP), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Orthopedic One (US), Centre International de Recherche en Infectiologie (FR), Galderma (Switzerland) (CH), University of Lübeck (DE), University of Rzeszów (PL)
Openalex Percentile: Top 4%
Dermatology and Skin Diseases
6.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.